• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

负压伤口治疗的使用会增加清创和植入物保留治疗急性人工关节感染的失败率。

The use of negative pressure wound therapy increases failure rate in debridement and implant retention for acute prosthetic joint infection.

机构信息

Department of Orthopaedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.

Orthopaedic and Trauma Surgery Centre, University Hospital Mannheim, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany.

出版信息

Technol Health Care. 2020;28(6):721-731. doi: 10.3233/THC-192095.

DOI:10.3233/THC-192095
PMID:32444587
Abstract

BACKGROUND

To date only scanty data exist regarding the effect of failed debridement, antibiotics, irrigation and retention of the prostheses (DAIR) and negative pressure wound therapy (NPWT) on the outcome of a subsequent exchange arthroplasty.

OBJECTIVE

The objective of this study was to determine the success rate of a two- or multi-stage procedure after initial failed DAIR/NPWT in patients with an acute periprosthetic joint infection (PJI) and to evaluate the influence of possible risk factors for treatment failure.

METHODS

Nineteen consecutive patients with a persisting PJI and ongoing NPWT after treatment of an acute PJI with DAIR of the hip or knee joint from October 2010 to June 2017 were included. All patients were treated according to a structured treatment algorithm after referral to our hospital. The endpoint was a successful reimplantation with absence of signs of infection two years after replantation ("replantation group") or treatment failure ("treatment failure group") in terms of a permanent girdlestone arthroplasty, fistula, amputation or death. A risk factor analysis was performed between the two groups.

RESULTS

Explantation was performed in 15 cases, amputation in one case, and DAIR/establishment of a fistula in three cases. The treatment success rate after reimplantation in terms of "definitively free of infection" two years after surgery according to Laffer was 36.85% (seven out of 19 patients). Statistical analysis revealed the number of surgeries until wound consolidation (p= 0.007), number of detected bacterial strains (p= 0.041), a polymicrobial PJI (p= 0.041) and detection of a difficult-to-treat organism (p= 0.005) as factors associated with treatment failure. After failed DAIR/NPWT we could detect a significant higher number of different bacterial strains (p= 0.001).

CONCLUSIONS

The treatment success rate after failed DAIR and NPWT with 36% is low and associated with a high treatment failure rate (permanent girdlestone arthroplasty, fistula or amputation, death). Thus, the definition of risk factors is crucial. We found that the number of revisions until wound consolidation, a polymicrobial PJI and detection of a difficult-to-treat organisms were risk factors for treatment failure. Furthermore, after failed DAIR/NPWT we could detect a significant higher number of different bacterial strains, with a possible adverse effect on a consecutive exchange.

摘要

背景

迄今为止,关于初次清创术、抗生素、灌洗和保留假体(DAIR)以及负压伤口治疗(NPWT)失败对随后的关节置换术结果的影响,仅有少量数据。

目的

本研究旨在确定髋关节或膝关节急性假体周围关节感染(PJI)初次 DAIR/NPWT 治疗失败后,行两期或多期手术的成功率,并评估可能的治疗失败危险因素的影响。

方法

2010 年 10 月至 2017 年 6 月,19 例髋关节或膝关节急性 PJI 患者行 DAIR 治疗后,持续 PJI 且持续 NPWT ,纳入本研究。所有患者均按我院制定的治疗方案进行治疗。研究终点为 2 年后无感染迹象的再次成功植入(“再植入组”)或永久性关节切除术、瘘管、截肢或死亡(“治疗失败组”)。对两组之间的危险因素进行了分析。

结果

15 例患者行假体取出术,1 例患者行截肢术,3 例患者行 DAIR/建立瘘管术。术后 2 年,根据 Laffer 标准,“明确无感染”的再植入治疗成功率为 36.85%(19 例患者中有 7 例)。统计学分析显示,伤口愈合前的手术次数(p=0.007)、检出的细菌数量(p=0.041)、混合感染性 PJI(p=0.041)和检出难处理的病原体(p=0.005)是与治疗失败相关的因素。初次 DAIR/NPWT 治疗失败后,我们可检测到明显更多的不同细菌菌株(p=0.001)。

结论

初次 DAIR 和 NPWT 治疗失败后,治疗成功率为 36%,治疗失败率高(永久性关节切除术、瘘管或截肢、死亡)。因此,危险因素的定义至关重要。我们发现,伤口愈合前的手术次数、混合感染性 PJI 和检出难处理的病原体是治疗失败的危险因素。此外,初次 DAIR/NPWT 治疗失败后,我们可检测到明显更多的不同细菌菌株,这可能对随后的关节置换术产生不利影响。

相似文献

1
The use of negative pressure wound therapy increases failure rate in debridement and implant retention for acute prosthetic joint infection.负压伤口治疗的使用会增加清创和植入物保留治疗急性人工关节感染的失败率。
Technol Health Care. 2020;28(6):721-731. doi: 10.3233/THC-192095.
2
[Treatment of Acute Periprosthetic Infections with DAIR (Debridement, Antibiotics and Implant Retention) - Success Rate and Risk Factors of Failure].[采用清创、抗生素和保留植入物(DAIR)治疗急性人工关节周围感染——成功率及失败风险因素]
Acta Chir Orthop Traumatol Cech. 2019;86(3):181-187.
3
A Comparison of Outcomes of Culture positive and Culture negative Acute Knee Prosthetic Joint Infection following Debridement, Antibiotics and Implant Retention (DAIR).清创术、抗生素保留和假体保留(DAIR)治疗下培养阳性和培养阴性急性膝关节假体关节感染的结局比较。
Eur J Orthop Surg Traumatol. 2023 Aug;33(6):2375-2383. doi: 10.1007/s00590-022-03445-2. Epub 2022 Nov 27.
4
Failed Debridement and Implant Retention Does Not Compromise the Success of Subsequent Staged Revision in Infected Total Knee Arthroplasty.感染性全膝关节置换术中清创和保留植入物失败并不影响后续分期翻修的成功率。
J Arthroplasty. 2019 Jun;34(6):1214-1220.e1. doi: 10.1016/j.arth.2019.01.066. Epub 2019 Feb 2.
5
The Double DAIR: A 2-Stage Debridement with Prosthesis-Retention Protocol for Acute Periprosthetic Joint Infections.双清创术:一种用于急性人工关节周围感染的保留假体的两阶段清创方案
JBJS Essent Surg Tech. 2021 Feb 4;11(1). doi: 10.2106/JBJS.ST.19.00071. eCollection 2021 Jan-Mar.
6
Does Prior Failed Debridement Compromise the Outcome of Subsequent Two-Stage Revision Done for Periprosthetic Joint Infection Following Total Knee Arthroplasty?初次清创失败是否会影响全膝关节置换术后假体周围关节感染二期翻修的结果?
J Arthroplasty. 2018 Aug;33(8):2588-2594. doi: 10.1016/j.arth.2018.02.087. Epub 2018 Mar 9.
7
Outcomes and risk factors for failure after débridement, antibiotics, and implant retention for elbow periprosthetic joint infection.肘关节假体周围感染清创、抗生素治疗及植入物保留术后失败的结局与危险因素
J Shoulder Elbow Surg. 2023 Mar;32(3):475-479. doi: 10.1016/j.jse.2022.11.009. Epub 2022 Dec 21.
8
Debridement, Antibiotics, and Implant Retention (DAIR) Plus Offers Similar Periprosthetic Joint Infection Treatment Success Rates to Two-Stage Revision in Oncologic Megaprosthesis.清创术、抗生素和植入物保留(DAIR)加用与肿瘤型假体的二期翻修相比,提供了相似的假体周围关节感染治疗成功率。
J Arthroplasty. 2024 Jul;39(7):1820-1827. doi: 10.1016/j.arth.2024.01.021. Epub 2024 Jan 14.
9
Functional outcome of debridement, antibiotics and implant retention in periprosthetic joint infection involving the hip: a case-control study.清创、抗生素治疗及保留植入物治疗髋关节假体周围感染的功能结局:一项病例对照研究
Bone Joint J. 2017 May;99-B(5):614-622. doi: 10.1302/0301-620X.99B5.BJJ-2016-0562.R2.
10
The Role of Long-Term Antibiotic Suppression in the Management of Peri-Prosthetic Joint Infections Treated With Debridement, Antibiotics, and Implant Retention: A Systematic Review.保留假体清创术联合抗生素治疗假体周围关节感染后长期抗生素抑制的作用:系统评价。
J Arthroplasty. 2020 Apr;35(4):1154-1160. doi: 10.1016/j.arth.2019.11.026. Epub 2019 Dec 9.

引用本文的文献

1
A Single Tertiary-Care Center Case Series Using Vertical Rectus Abdominis Myocutaneous Flap in the Management of Complex Periprosthetic Joint Infection of the Hip.一个三级医疗中心的病例系列:采用腹直肌肌皮瓣垂直移位治疗复杂的人工髋关节周围感染
Microorganisms. 2025 Aug 21;13(8):1962. doi: 10.3390/microorganisms13081962.
2
Microbiological Trends and Antibiotic Susceptibility Patterns in Patients with Periprosthetic Joint Infection of the Hip or Knee over 6 Years.6年期间髋或膝关节假体周围感染患者的微生物学趋势及抗生素敏感性模式
Antibiotics (Basel). 2022 Sep 13;11(9):1244. doi: 10.3390/antibiotics11091244.
3
Microbiological Profiles of Patients with Periprosthetic Joint Infection of the Hip or Knee.
髋关节或膝关节人工关节感染患者的微生物学特征
Diagnostics (Basel). 2022 Jul 7;12(7):1654. doi: 10.3390/diagnostics12071654.
4
Analysis of Failed Two-Stage Procedures with Resection Arthroplasty as the First Stage in Periprosthetic Hip Joint Infections.以切除关节成形术作为第一阶段治疗人工髋关节周围感染的两阶段手术失败病例分析。
J Clin Med. 2021 Nov 5;10(21):5180. doi: 10.3390/jcm10215180.
5
Synovial Complement Factors in Patients with Periprosthetic Joint Infection after Undergoing Revision Arthroplasty of the Hip or Knee Joint.髋关节或膝关节翻修置换术后假体周围关节感染患者的滑膜补体因子
Diagnostics (Basel). 2021 Mar 4;11(3):434. doi: 10.3390/diagnostics11030434.